Item(by='tboyd47', descendants=None, kids=[24804568, 24801337], score=None, time=1602859737, title=None, item_type='comment', url=None, parent=24800435, text='Look at the timeline, people:<p>&gt; In a trial in China over February–March 2020, remdesivir was not effective in reducing the time for improvement from COVID‑19 or deaths, and caused various adverse effects, requiring the investigators to terminate the trial. [1]<p>&gt; On 17 March 2020, Didier Raoult announced in an online video that a trial involving 24 patients from southeast France supported the claim that hydroxychloroquine and azithromycin were effective in treating for COVID-19.[0]<p>&gt; On 18 March 2020, the World Health Organization (WHO) announced the launch of a trial that would include one group treated with remdesivir. [1]<p>&gt; As of April 2020, remdesivir was viewed as the most promising treatment for COVID‑19... [1]<p>---<p>[0]: <a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Hydroxychloroquine#COVID-19" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Hydroxychloroquine#COVID-19</a><p>[1]: <a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Remdesivir" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Remdesivir</a>')